Top Markets
Coin of the day
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Classement en actions #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Prix de l'action
$10.35
Capitalisation boursière
$6.19B
Changement (1 jour)
3.79%
Changement (1 an)
4.34%
Pays
CN
Échange Gan & Lee Pharmaceuticals. (603087)

Catégorie

Historique du prix de l'action pour Gan & Lee Pharmaceuticals. (603087)
Prix de clôture le plus élevé : $10.41 le 2026-08-01

Prix de clôture le plus bas : $9.67 le 2020-06-01
Historique du prix de l'action de Gan & Lee Pharmaceuticals. de 2020 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.64%
2025 49.04%
2024 -17.59%
2023 56.66%
2022 -56.78%
2021 -39.34%
2020 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$371.13 -21.75%
US
$188.78 -39.02%
FR
$161.64 23.75%
JP
$189.94 24.49%
US
$76.37 -5.96%
CH